Embed Size (px)
Citation preview
Expanding the role of covered stents for aneurysmal and stenotic lesions
M.H.Tenholt
Vascular and Endovascular Surgery
Theresien Hospital Mannheim - Germany
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Superior patency for iliac stenting
Iliac stenting Patency @12 months 18 months 24 months 60 months
CS 95% BMS 82% Sabri et al CS 92% 92% BMS 78% 62% Bosiers et al CS 91% Dartmouth et al CS 87% BMS 53%Cerezo et al CS 100% 86%
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Renal and visceral stenting Patency at:12 months 24 months 36 months
Renal Mohabbat/Greenberg et al CS 95% BMS 83% Hassis et al CS 100% 93% BMS 83% 74%
Mesenteric Lesar et al CS 100% BMS 54% Oderich et al CS 92% BMS 52%
Superior patency for renal and visceral stenting
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
eCovered stent applications
Trauma cases/ruptures/bail out
Occlusive disease
Aneurysms
Coarctations
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Aneurysms: FEVAR
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
eAneurysms: Ch-EVAR
chimney technique
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Iliac aneurysms
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
eIntroducing
V12
Balloon expandable Steel Totally PTFE covered
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
eIntroducing
V12
Premounted Over 150.000 implants Over 150 publications
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Ability to customize and post-dilate Flexible because of open cell design
Thermo-conformable ePTFE covering
flared end cone shape
flexible design
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
V12 minimizes embolic debris
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
eIn-stent restenosis:
bare metal stent vs covered stent
PTFE stent after 28 days
Uncovered stent after 28 days
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Full range of stents
5 – 22 mm range
5- 11 Fr.
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e66 yearLeriche-Syndrome
Therapy: Stent-Angioplasty in Kissing-Ballon-technique
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
71 yearTasc D lesion
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e62 year
Redo case after com/ext Iliac Stent PTA 2008
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e54 year
Aortic/ Iliac ulcer ,Art.iliaca com re,PAD Rutherford 3
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
K,WF64 pAVK4re, Niereninsuffizienz St.3
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
E,W78 sympt. ACI Stenose
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
E,W78 sympt. ACI Stenose
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e59 year
Aneurysm Right Internal Iliac, dilat. Angiopathy
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
S,R59 Aneurysma Art. Iliaca int re,dilat. Angiopathie
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
S,R59 Aneurysma Art. Iliaca int re,dilat. Angiopathie
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
S,R59 Aneurysma Art. Iliaca int re,dilat. Angiopathie
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
S,R59 Aneurysma Art. Iliaca int re,dilat. Angiopathie
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
S,R59 Aneurysma Art. Iliaca int re,dilat. Angiopathie
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
S,R59 Aneurysma Art. Iliaca int re,dilat. Angiopathie
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e73 year
PAOD Rutherford 2 Aneurysm exclusion in aortobiiliacal position
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e60 year PAOD Rutherford 3 Leriche Syndrom
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e58 yearPAOD Rutherford 2 on both sides
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e66 year
PAOD Rut. 3 bilateral
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
52 yearAV Fistulal VCI after Spondylodesis
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e87 year
High grade in-stent restenosis after carotid stent - 30.09.2011
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e45 year
RezIn Stent restenosis left subclavian artery with subclavian steal Syndrome
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Mat
thia
s.T
enho
lt@th
eres
ienk
rank
enha
us.d
e
Conclusion V12 Covered Stents
Covered stent: not only for acute problems
Covered stents are the prefered implants in aortoiliac occlusive lesions (TASC C & D lesions)
Can be used in plaque ulcerations and small aneurysmal/occlusive lesions
Usefull as a “stent in-stent“ concept in redo cases and they are then preferable to open surgery
Expanding the role of covered stents for aneurysmal and stenotic lesions
Thank you
Dr. M.H.Tenholt
![Journal Papers [1-44] - biosensors.com · Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease: Final](https://img.pdfslide.tips/doc/110x75/5fae34968d5e227c587bb762/journal-papers-1-44-polymer-based-biolimus-eluting-stents-versus-durable-polymer-based.jpg)
